Skip to main content
HR

Headlands Research

Headlands Research operates a multinational network of integrated clinical trial sites that specialize in high‑volume recruitment and retention of diverse patient populations across CNS, mental health, vaccines, and metabolic/endocrine therapeutic areas. By leveraging extensive site databases and strong physician partnerships, the company provides end‑to‑end site management—including study start‑up, regulatory compliance, data collection, and patient follow‑up—to help pharmaceutical sponsors and CROs accelerate enrollment, reduce operational complexity, and obtain reliable, high‑quality trial data.

Lake Worth, US,CA,PRFounded 201818410K+ followers
Updated 2 months ago

Funding

$1.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Pharmaceutical sponsors and contract research organizations often struggle to find clinical trial sites that can enroll large, diverse patient populations quickly and maintain high-quality data across multiple therapeutic areas. Limited site capacity and fragmented networks can delay study timelines and increase costs.

Solution

Headlands Research operates a multinational network of integrated clinical trial sites focused on high-volume patient recruitment and retention. By leveraging extensive site databases and strong physician partnerships, the organization can match sponsors with sites that have access to inclusive, diverse populations. The network spans core therapeutic pillars—including CNS, mental health, vaccines, and metabolic/endocrine disorders—and is supported by a large team of clinical research professionals and principal investigators. Headlands provides end‑to‑end site management, from study start‑up and regulatory compliance to data collection and patient follow‑up, ensuring consistent, high‑quality results across all locations. Sponsors benefit from accelerated enrollment, reduced operational complexity, and reliable data to advance their medical therapies.

Target Audience

Primary customers are pharmaceutical companies and contract research organizations seeking reliable, high‑volume clinical trial sites for multi‑therapeutic studies, particularly those requiring diverse participant populations.

Features

  • Multinational portfolio of clinical sites with proven capacity to enroll thousands of participants per trial
  • Dedicated physician networks and site databases that enable rapid identification of eligible, diverse patient cohorts
  • Expertise across four therapeutic pillars (CNS, mental health, vaccines, metabolic/endocrine) to support a wide range of study designs
  • Experienced clinical research staff and principal investigators ensuring regulatory compliance and high‑quality data capture
  • Integrated site management services covering study start‑up, patient recruitment, retention strategies, and ongoing monitoring
  • Centralized coordination to streamline communication between sponsors, CROs, and individual sites
This profile is AI-generated and may contain inaccuracies.